WORLD HEALTH ORGANIZATION
ORGANISATION MONDIALE DE LA SANTE
REGIONAL OFFICE FOR THE WESTERN PACIFIC BUREAU REGIONAL DU PACIFIQUE OCCIDENTAL
REGIONAL COMMITTEE Fiftieth session Macao 13–17 September 1999 Provisional agenda item 21.2
WPR/RC50/18 15 July 1999 ORIGINAL: ENGLISH
ESSENTIAL DRUGS AND OTHER MEDICINES: MEMBERSHIP OF THE MANAGEMENT ADVISORY COMMITTEE
The Management Advisory Committee (MAC) is an advisory body to the Director-General of WHO on the Department of Essential Drugs and Other Medicines. It was created to replace the Meeting of Interested Parties. The Department of Essential Drugs and Other Medicines includes the former Action Programme on Essential Drugs and most components of the Division of Drug Management and Policies. There are three categories of membership. Category (b) membership comprises members selected by the WHO regional committees. There are two representatives of Member States from each of WHO’ s six regions, including the Western Pacific Region, under this category. The term of one category (b) member, Mongolia, will expire on 31 December 1999. The Regional Committee is requested to select one member to represent the Region under category (b), effective 1 January 2000, for a three-year term.
WPR/RC50/18 page 2
The terms of reference of the Management Advisory Committee, including its functions, composition, operation and review, are given in the Annex. There are three categories of membership: (1) Category (a) is composed of government representatives from those countries which
contributed funding in support of the Drug Action Programme’ s (now Essential Drugs and Other Medicines) budget in the previous two years. (2) Category (b) is composed of two Member States undertaking drug policy and programme
development from each of WHO’ s six regions selected by the respective regional committees for three-year terms. Regional committees, responsible for choosing representatives, are asked to select from countries undertaking drug policy and programme development. (3) Category (c) is composed of major international organizations collaborating in the
implementation of WHO’ s Revised Drug Strategy, such as UNDP, UNICEF, UNIDO and the World Bank. Since September 1992, the status of category (b) members selected by the Regional Committee from among Member States of the Western Pacific Region has been as follows: Member Malaysia China Papua New Guinea Cambodia Mongolia Viet Nam Year elected 1990 1991 1993 1994 1996 1997 Term of office 1 January 1991–31 December 1993 1 January 1992–31 December 1994 1 January 1994–31 December 1996 1 January 1995–31 December 1997 1 January 1997–31 December 1999 1 January 1998–31 December 2000
The term of office of Mongolia under category (b) membership will expire on 31 December 1999.1 To fill this vacancy, it will be necessary for the Regional Committee to select, at its fiftieth session, one member from the Western Pacific Region under category (b) for the period 1 January 2000 to 31 December 2002.
1
See resolution WPR/RC45.R14, Handbook of Resolutions and Decisions of the Regional Committee for the Western Pacific, Vol. III, Fifth edition, (1986–1995), Manila: World Health Organization, 1996, p.47.
WPR/RC50/18 page 3
ANNEX
MANAGEMENT ADVISORY COMMITTEE (MAC)
Terms of reference of the Management Advisory Committee The Management Advisory Committee (MAC) represents the interests and responsibilities of WHO’ s external partners collaborating with WHO in its Action Programme on Essential Drugs. It acts as an advisory body to the Director-General of WHO, making recommendations on matters related to the policy, strategy, finance, management, monitoring and evaluation of the WHO Action Programme on Essential Drugs (DAP).2 Functions − Review, analyse and guide the programme of activities and related budget of DAP and make appropriate recommendations to the Director-General. − Review the arrangements envisaged by the Director-General for financing and managing DAP. − − − Review proposed longer-term plans of action and their financial implications. Review financial statements of DAP. Review periodic reports evaluating the progress of DAP towards the achievement of its objectives and submit its findings and recommendations to the Director-General. − Recommend ways of improving, as appropriate, coordination between the activities of DAP and of other relevant programmes and organizations. − Consider any other matters relating to DAP referred to it by the Director-General, the Director of DAP or any member of the Committee.
2
The Department of Essential Drugs and Other Medicines includes the former Action Programme on Essential Drugs and most components of the Division of Drug Management and Policies. The terms of reference may be changed to reflect new approaches.
WPR/RC50/18 page 4
Annex
In carrying out its functions, MAC shall be informed of all policy decisions and recommendations concerning DAP or WHO’ s Revised Drug Strategy made by the World Health Assembly and the Executive Board. Composition Members − The government representatives of those countries which contributed funding in support of DAP’ s budget in the previous two years; − Two Member States undertaking drug policy and programme development from each of WHO’ s six regions selected by the respective regional committees for three-year terms. Regional Committees, responsible for choosing representatives, should be asked to select from countries undertaking drug policy and programme development; − Major international organizations collaborating in the implementation of WHO’ s Revised Drug Strategy, such as UNDP, UNICEF, UNIDO and the World Bank. Observers Other concerned parties invited by the Director-General to attend as observers. Members selected from the six regions of WHO may be reappointed. The Chairperson of MAC shall, in principle, be a government representative and shall be elected from and by members of MAC for a period of two years, but, while eligible for re-election, may not serve consecutive terms. The Chairperson shall preside over meetings of MAC and undertake whatever additional duties may be assigned by MAC, in agreement with the Director-General of WHO. Observers are encouraged to take part in the deliberations of the MAC. Operation The MAC shall meet once a year. The meeting shall concentrate on reviewing DAP’ s
programme in light of the financial support that will have been pledged and the past, present, and future coordination of external support for DAP’ s principal areas of activity (country support, development work, operational research, and management). The meeting shall also review and guide the following year’ s programme and related budget. The MAC may also meet more often upon the
WPR/RC50/18 page 5
Annex
proposal of either its Chairperson or the Director-General of WHO, and with latter’ s agreement. MAC shall decide its method of work, which may include the establishment of a number of functional subcommittees. All such subcommittees shall have an advisory role to MAC. Each MAC meeting shall elect a rapporteur from among its members who shall assist in ensuring that the decisions reached by the meeting are adopted and recorded before its closure. The MAC should, whenever possible, adopt its conclusions by consensus. Director, DAP shall be the Secretary of the MAC. For these purposes, MAC shall be assisted in its endeavours by the provision by WHO of whatever secretariat and other support services may be considered necessary and reasonable.